Understanding Shared Clinical & Molecular Features Across IPF and Autoimmune-Related ILD

•  Exploring overlap in clinical presentation, progression patterns, and outcomes across IPF and CTD-ILD
• What emerging molecular and biomarker insights reveal about shared and distinct disease mechanisms in fibrotic ILDs
• Implications for diagnosis, patient stratification, and therapeutic development across heterogeneous ILD populations

Speakers:

Rachel Knipe

physician scientist

Harvard Medical School